Cadrenal Therapeutics (CVKD) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Rocket One is the larger company by market cap ($7.4 million vs $7.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | RKTO |
|---|---|---|
| Share price | $1.70 | $0.297 |
| Market cap | $7.01M | $7.39M |
| 1-day change | +0.59% | +5.24% |
| YTD return | — | -70.00% |
| 1-year return | — | -72.63% |
| 5-year return | — | -98.60% |
| EPS (TTM) | $-3.67 | $-0.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-13.24M | $-12.47M |
| 52-week high | $12.50 | $2.45 |
| 52-week low | $0.816 | $0.26 |
| Distance from 52-week high | -86.40% | -87.88% |
| Analyst consensus | none | — |
| Avg. price target upside | +723.53% | — |
| Average volume | 496.14K | 338.12K |
| Shares outstanding | 4.12M | 24.90M |
| Employees | 5 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
CVKD vs RKTO FAQ
Which is bigger, Cadrenal Therapeutics or Rocket One?
Rocket One (RKTO) is larger, with a market capitalization of $7.39M compared with $7.01M for Cadrenal Therapeutics (CVKD).
Are Cadrenal Therapeutics and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.